Back to Journals » OncoTargets and Therapy » Volume 9

Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study

Total article views   HTML views PDF downloads Totals
8,629 Dovepress* 7,717+ 1,274 8,991
PubMed Central* 912 214 1,126
Totals 8,629 1,488 10,117
*Since 3 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar